Adastra Holdings Ltd. (XTXXF) stock
XTXXFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2022, year ended Dec 31, 2022Last filing: 20-F on May 17, 2023
$0.01+0.00 (0.00%)
Close on Oct 19, 2026
Adastra r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2022 it was C$0, down 100.0% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | C$0 | -100.0% |
| FY2021 | Dec 31, 2021 | C$89.27K | -50.9% |
| FY2020 | Dec 31, 2020 | C$181.75K | – |
See a number that looks wrong?